Repeated Cannabinoid Exposure Changed Retinal CB1 Signaling and Experimental Neuroprotection in Rats

A rat retinal study found that repeated cannabinoid exposure reduced CB1 expression and altered subsequent protection against an experimental excitotoxic injury. Lower-dose HU-210 conditions showed protection where other repeated-treatment conditions did not.

The tissue and injury model were specific

Researchers studied normal rat retina and an AMPA excitotoxicity model using anandamide, methanandamide and HU-210. Receptor expression, signaling-protein phosphorylation and selected amacrine-cell outcomes were measured. This was not a clinical trial of cannabis for vision preservation.

Expression and downstream responses differed by compound

Repeated exposure reduced CB1 expression under several conditions, while a lower tested dose did not. HU-210 and methanandamide affected selected Akt or ERK phosphorylation measures. Anandamide did not produce those same downstream changes. The abstract does not support treating all three compounds as identical signaling interventions.

Protection was not guaranteed by cannabinoid exposure

The three compounds failed to protect the selected amacrine cells under one repeated-treatment condition, whereas lower HU-210 doses were protective. This suggests a dose- and regimen-sensitive relationship. It does not establish that receptor downregulation alone caused loss of protection or that a consumer low dose would reproduce the result.

The study contributes evidence that repeated exposure may alter a cannabinoid's subsequent effect in retina. Its clinical implications remain limited by the animal model, selected cell population and laboratory injury. It cannot establish a treatment for retinal disease or a safe human dosing strategy.

Related: interpreting cannabis tolerance claims.

Research cited

Papadogkonaki S; Theodorakis Κ; Thermos K. Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina. Experimental eye research (2019). doi:10.1016/j.exer.2019.107694. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

A female-rat feeding study found that THC increased fat intake in one access schedule while rimonabant reduced intake in another. The feeding history and experimental group mattered to the direction and persistence of the response. Limited access created different eating patterns Rats had unrestricted chow and water, with groups differing…

Spread the love

Read Article: THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

In a mouse THC study, mTOR inhibition prevented selected memory-related effects when given before exposure but did not prevent a residual cognitive deficit when introduced after chronic THC stopped. Timing changed the intervention's result. Acute effects separated by endpoint Temsirolimus prevented acute anxiety-like and amnesic-like effects. THC-related anxiolysis, hypothermia, reduced…

Spread the love

Read Article: mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

A mouse study found that repeated lower-dose JZL184 preserved antinociceptive and gastroprotective effects that became tolerant under higher-dose regimens. The result supports a dose-dependent experimental window, not a validated human treatment schedule. Two disease-related models were used Researchers examined neuropathic pain after sciatic nerve constriction and gastric hemorrhage induced by…

Spread the love

Read Article: Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us